Heritable human genome editing: making ‘societal dialogue’ meaningful
By Jackie Leach Scully,
Nuffield Council on Bioethics
| 10. 02. 2020
The Consensus Study Report of the International Commission on the Clinical Use of Human Germline Genome Editing, produced by an international commission convened by the US National Academies of Medicine and Sciences and the UK’s Royal Society, is careful to state that its focus is firmly on the scientific and technical sides of heritable human genome editing (HHGE) rather than the social and ethical. Although other commentators have properly pointed out the artificiality of that divide and the implausibility of a science untouched by social and ethical values, it is nevertheless a step in the right direction of acknowledging that HHGE’s ethical and social implications are of a scale that requires something more than a couple of chapters tucked in at the end of a report.
The Consensus Study Report still has much in common with earlier reports that gave more houseroom to ethical issues, including the National Academies’ earlier (and broader) Human genome editing: science, ethics, and governance (2017) and the Nuffield Council on Bioethics’ own two reports, Genome editing: an ethical review (2016) and Genome editing and...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...